[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0022-2623&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=A1984SB1240002
[[sponsorship]]細胞與個體生物學研究所,基因體研究中心[[note]]已出版;有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gat...
Two series of aminoguanidines containing an alkynyl moiety were designed, synthesised, and screened ...
靶向血管的抗肿瘤药物、抗乏氧细胞毒药物、抗信号传导药物、单克隆抗体等抗肿瘤新靶点药物的开发应用使肿瘤内科治疗扩展至新的领域.该类药物与传统的细胞毒药物联合应用有望将多种肿瘤的缓解率及生存期提高到新的水...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
Hydroxyguanidine, with the imino group of guanidine and the hydroxyamino group of hydroxyurea, has f...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]化學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gate...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]細胞與個體生物學研究所,基因體研究中心[[note]]已出版;有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gat...
Two series of aminoguanidines containing an alkynyl moiety were designed, synthesised, and screened ...
靶向血管的抗肿瘤药物、抗乏氧细胞毒药物、抗信号传导药物、单克隆抗体等抗肿瘤新靶点药物的开发应用使肿瘤内科治疗扩展至新的领域.该类药物与传统的细胞毒药物联合应用有望将多种肿瘤的缓解率及生存期提高到新的水...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
Hydroxyguanidine, with the imino group of guanidine and the hydroxyamino group of hydroxyurea, has f...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]分子生物研究所[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]化學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gate...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
[[sponsorship]]細胞與個體生物學研究所,基因體研究中心[[note]]已出版;有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gat...
Two series of aminoguanidines containing an alkynyl moiety were designed, synthesised, and screened ...
靶向血管的抗肿瘤药物、抗乏氧细胞毒药物、抗信号传导药物、单克隆抗体等抗肿瘤新靶点药物的开发应用使肿瘤内科治疗扩展至新的领域.该类药物与传统的细胞毒药物联合应用有望将多种肿瘤的缓解率及生存期提高到新的水...